Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Gender-Affirming Stigma Intervention to Improve Substance Misuse and HIV Risk Among Transgender Women

NCT06880705 is registered in ClinicalTrials.gov with Illinois Institute of Technology as lead sponsor.

NCT NCT06880705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06880705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Gender-Affirming Stigma Intervention to Improve Substance Misuse and HIV Risk Among Transgender Women
Lead sponsor
Illinois Institute of Technology
Phase
Not applicable
Overall status
Recruiting
Start date
April 14, 2026
Completion date
July 31, 2027
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv), substance abuse, substance addiction, substance use (drugs, alcohol), substance use disorder (sud)